Unlocking the Future of the Drug-Coated Balloons Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the drug-coated balloons market size evolved in recent years?
The size of the drug-coated balloons market has seen swift expansion in the last few years. Projections indicate a growth from $1.08 billion in 2024 to $1.24 billion in 2025, maintaining a compound annual growth rate (CAGR) of 15.4%. The growth in this past period is due to factors such as the rising prevalence of cardiovascular disease, an increase in demand for less invasive procedures, widespread peripheral artery disease (PAD), a decrease in restenosis rates, and advancements in the field of interventional cardiology.
What are the predictions for the drug-coated balloons market size in the coming years?
The market size of drug-coated balloons is predicted to experience significant growth in the coming years. An expansion to “$2.22 billion by 2029” is anticipated, with a compound annual growth rate (CAGR) of 15.6%. Factors contributing to the growth during the projected period include a rising aging demographic, broadening of indications and applications, a focus on outpatient and ambulatory assistance, combination with drug delivery developments, and global health initiatives. Foreseen trends within this forecast period encompass regulatory endorsements for new mixes, an emphasis on reducing side effects, the introduction of bioresorbable coatings, market growth in budding economies, and patient-oriented strategies.
Get your drug-coated balloons market report here!
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report
What key factors are fueling the growth of the drug-coated balloons market?
The increasing incidence of coronary artery disease is anticipated to drive the growth of the drug-coated balloons market. Defined as the narrowing or blockage of arteries that supply blood to the heart muscle, coronary artery disease (CAD) often leads to heart attacks. Drug-coated balloons are used in the medical treatment of this condition by releasing drugs into the artery during a procedure to avert restenosis, or the subsequent narrowing of the artery post-angioplasty. In August 2022, a study published in the Journal of the American College of Cardiology, a US-based organization, predicted an increase in all four cardiovascular risk factors within the U.S. population between 2025 and 2060. It projected diabetes to experience the greatest increase at 39.3%, followed by dyslipidemia (27.6%), hypertension (25.1%), and obesity (18.3%). The report also showed a projected higher rate in heart failure (33.4%) and ischemic heart disease (30.7%), before heart attack (16.9%) and stroke (33.8%). Consequently, the expected increase in coronary artery disease prevalence is set to stimulate the drug-coated balloon market.
How is the global drug-coated balloons market divided into key segments?
The drug-coated balloons market covered in this report is segmented –
1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers
Subsegments:
1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons
3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp
Who are the key firms paving the way for growth in the drug-coated balloons market?
Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed
Which trends are expected to transform the drug-coated balloons market?
The trend of product innovations is becoming increasingly prevalent in the drug-coated balloon market. Major industry players in this market are concentrating on the development of novel technological and innovative solutions to consolidate their market presence. For example, in August 2022, Becton, Dickinson, and Company (BD), a medical technology firm based in the US, commenced the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). The objective of this trial is to examine the safety and efficacy of the sirolimus DCB in managing peripheral artery disease, a health issue that substantially affects both mobility and the quality of life of patients.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829
What regions are contributing significantly to the growth of the drug-coated balloons market?
North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
Pain Management Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
